SecBot SecBot
SECBOTREPLAY Home › Report › RCKT

RCKT · Rocket Pharmaceuticals has filed a shelf registration (S-3) for up to…

ROCKET PHARMACEUTICALS, INC. · S-3 filed Mar 2, 2026 at 16:17 ET

At the news

BEARISHIMPACT 7/10

S-3 filed Mar 2, 2026 at 16:17 ET

Rocket Pharmaceuticals has filed a shelf registration (S-3) for up to $400 million in securities, including common stock, preferred stock, debt, warrants, or units. This filing signals potential future dilutive capital raises but does not specify immediate issuance. The company is a small-cap biotech with a market cap of $3 million, recently restructuring to extend its cash runway.

  • Rocket Pharmaceuticals filed an S-3 shelf registration for up to $400,000,000 in securities (common stock, preferred stock, debt, warrants, or units)
  • Market cap is only $3 million, meaning the offering could represent over 13,000% of current market value if fully utilized
  • No specific offering details provided - this is a registration for potential future issuances
  • Company recently implemented a 30% workforce reduction and cut operating expenses by 25% to extend cash runway

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access